$27.49
+0 (+0%)
At Close: Dec 13, 2024
Silk Road Medical to Present at the Stifel 2021 Virtual Healthcare Conference
04:10pm, Tuesday, 02'nd Nov 2021
SUNNYVALE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wi
Will Silk Road Medical (SILK) Report Negative Earnings Next Week? What You Should Know
04:06pm, Tuesday, 02'nd Nov 2021
Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Silk Road Medical (SILK) a Great Growth Stock?
10:23am, Thursday, 30'th Sep 2021
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Silk Road Medical (SILK).
Silk Road Medical (SILK) Upgraded to Buy: Here's Why
01:33pm, Wednesday, 29'th Sep 2021
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Silk Road Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
04:10pm, Wednesday, 01'st Sep 2021
SUNNYVALE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company w
First Ever Analysis of TCAR in Standard Surgical Risk Patients Demonstrates Clinical Benefits in Large Comparative Dataset
04:15pm, Wednesday, 18'th Aug 2021
Large-Scale Analysis of TCAR in The Treatment of Standard Surgical Risk Patients Presented at The Society for Vascular Surgery 2021 Vascular Annual Meeting
Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2021 Results - Earnings Call Transcript
03:58pm, Saturday, 31'st Jul 2021
Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q2 2021 Results - Earnings Call Transcript
SILK Stock Increases Over 16%: Why It Happened
02:09pm, Friday, 30'th Jul 2021
The stock price of Silk Road Medical Inc (NASDAQ: SILK) increased by over 16% during intraday trading. This is why it happened.
Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates
07:46pm, Thursday, 29'th Jul 2021
Silk Road Medical (SILK) delivered earnings and revenue surprises of 16.22% and 4.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Silk Road Medical Reports Second Quarter 2021 Financial Results
04:05pm, Thursday, 29'th Jul 2021
SUNNYVALE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial resul
Silk Road Medical to Report Second Quarter 2021 Financial Results on July 29, 2021
04:05pm, Friday, 16'th Jul 2021
SUNNYVALE, Calif., July 16, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report
First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting
04:05pm, Tuesday, 06'th Jul 2021
SUNNYVALE, Calif., July 06, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that key data
Silicon Valley-Based Silk Road Medical Announces Expansion to MSP Region
04:05pm, Tuesday, 22'nd Jun 2021
SUNNYVALE, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, recently announced the openin
Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q1 2021 Results - Earnings Call Transcript
01:25am, Monday, 10'th May 2021
Silk Road Medical, Inc. (SILK) CEO Erica Rogers on Q1 2021 Results - Earnings Call Transcript
Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates
08:17pm, Tuesday, 04'th May 2021
Silk Road Medical (SILK) delivered earnings and revenue surprises of 22.50% and 3.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Sign In
Buy SILK